PDF herunterladen
Nuklearmedizin 1987; 26(01): 1-6
DOI: 10.1055/s-0038-1624353
Review Articles
Schattauer GmbH

A Molecular Approach to Immunoscintigraphy: A Study of the T-Antigen Conformation on the Surface of Tumors[*]

A. Noujaim
1   From the Faculty of Pharmacy and Pharmaceutical Sciences, University of Saskatchewan, Saskatoon, Sask., Canada
,
S. Selvaraj
1   From the Faculty of Pharmacy and Pharmaceutical Sciences, University of Saskatchewan, Saskatoon, Sask., Canada
,
M. R. Suresh
1   From the Faculty of Pharmacy and Pharmaceutical Sciences, University of Saskatchewan, Saskatoon, Sask., Canada
,
G. McLean
2   Dept, of Immunology, University of Saskatchewan, Saskatoon, Sask., Canada
,
D. Willans
2   Dept, of Immunology, University of Saskatchewan, Saskatoon, Sask., Canada
,
C. Turner
1   From the Faculty of Pharmacy and Pharmaceutical Sciences, University of Saskatchewan, Saskatoon, Sask., Canada
,
D. M. Haines
3   Faculty of Medicine, University of Alberta, Edmonton, Alberta, and the Faculty of Veterinary Medicine, University of Saskatchewan, Saskatoon, Sask., Canada
,
M. Longenecker
2   Dept, of Immunology, University of Saskatchewan, Saskatoon, Sask., Canada
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received: 08. Juli 1986

Publikationsdatum:
04. Februar 2018 (online)

    Lizenzen und Reprints

The role of glycoconjugates in tumor cell differentiation has been well documented. We have examined the expression of the two anomers of the Thomsen-Friedenreich antigen on the surface of human, canine and murine tumor cell membranes both in vitro and in vivo. This has been accomplished through the synthesis of the disaccharide terminal residues in both a and ß configuration. Both entities were used to generate murine monoclonal antibodies which recognized the carbohydrate determinants. The determination of fine specificities of these antibodies was effected by means of cellular uptake, immunohistopathology and immunoscintigraphy. Examination of pathological specimens of human and canine tumor tissue indicated that the expressed antigen was in the β configuration. More than 89% of all human carcinomas tested expressed the antigen in the above anomeric form. The combination of synthetic antigens and monoclonal antibodies raised specifically against them provide us with invaluable tools for the study of tumor marker expression in humans and their respective animal tumor models.

Zusammenfassung

Die Rolle von Glykokonjugaten bei der Tumorzelldifferenzierung ist gut dokumentiert. Wir haben die Expression der zwei Anomere des Thomsen- Friedenreich-Antigens an der Oberfläche von Tumorzellmembranen des Menschen, Kaninchens, der Ratte und Maus sowohl in vitro als auch in vivo untersucht. Dies wurde durch die Synthese der Disaccharid-Endgruppen sowohl in Alphawie in Betakonfiguration bewerkstelligt. Beide Gruppen wurden dazu benutzt, um monoklonale Antikörper der Maus zu erzeugen, welche die Karbohydrat-Determinanten erkannten. Die Bestimmung von fünf Spezifitäten dieser Antikörper wurde anhand der zellulären Aufnahme, Immunhistopathologie und Immunszintigraphie vorgenommen. Die Untersuchung pathologischer Proben von Tumorgewebe des Menschen und Kaninchens zeigte, daß das exprimierte Antigen in der Betakonfiguration war. Mehr als 89% aller getesteten menschlichen Karzinome exprimierten das Antigen in dieser anomerischen Form. Die Kombination von synthetischen Antigenen und spezifisch gegen sie gerichteten monoklonalen Antikörpern liefert uns unschätzbare Werkzeuge für das Studium der Tumormarker-Expression in menschlichen und ihm entsprechenden tierischen Tumormodellen.

* Presented at the Symposion on “Monoclonal Antibodies in Nuclear Medicine” in Freiburg i. Br., May 1–3, 1986.


 

  • REFERENCES

  • 1 Abdi E., Kamitomo V., Catz Z.. et al. Radioiodinated lectin: Clinical use as a tumor imaging agent and potential use in assessing renal tubular function. Eur. J. nucl. Med 1986; 11: 350-4.
    PubMedGoogle Scholar
  • 2 Bernstein M. A, Hall L. D. A general synthesis of model glycoproteins: Coupling of alkenyl glycosides to proteins, using reductive animation with sodium cyanoborohydride. Carbohydr. Res 1980; 78: C1-C3.
    Google Scholar
  • 3 Boniface G. R, Shysh A., Longenecker B. M. et al. Renal tubular receptor imaging with 131I labeled peanut lectin: Pharmacokinetics and renal clearance mechanism in animals. J. nucl. Med 1986; 27: 668.
    PubMedGoogle Scholar
  • 4 Boniface G. R, Selvaraj S., Suresh M. R. et al. Synthetic glycosylated H.S.A. analogues for hepatocyte receptor imaging. In: Current Applications in Radiopharmacology. Billinghurst M.. ed. 157-64 Pergamon Press; Oxford: 1986
    Google Scholar
  • 5 Cianfriglia M., Armellini D., Massone A., Mariani M.. Simple immunization protocol for high frequency production of soluable antigen specific hybridomas. Hybridoma 1983; 02: 451-7.
    CrossrefPubMedGoogle Scholar
  • 6 Dubous M., Gilles K. A, Hamilton J. K, Rebers P. A, Smith F.. Colorimetric method for determination of sugars and related substances. Anal. Chem 1956; 28: 350-6.
    CrossrefGoogle Scholar
  • 7 Feizi T.. Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are oncodevelopmental antigens. Nature 1985; 314: 53-7.
    CrossrefPubMedGoogle Scholar
  • 8 Feizi T., Gooi H. C, Childs R. A. et al. Tumor associated and differentiation antigens on the carbohydrate moieties of mucin-type glycoproteins. Biochem. Soc. Transact 1984; 607th Meeting: 591-6.
    PubMedGoogle Scholar
  • 9 Habu S., Kasai M., Nagai Y.. et al. The glycolipid asialoGMl as a new differentiation marker of fetal thymocytes. J. Immunol 1980; 125: 2284-8.
    PubMedGoogle Scholar
  • 10 Hakomori S. I. Tumor-associated carbohydrate antigens. Amer. Rev. Immunol 1984; 02: 103-26.
    Google Scholar
  • 11 Hakomori S. I, Kammagi R.. Glycosphingolipids as tumor associated and differentiations markers. JNCI 1983; 71: 231-51.
    PubMedGoogle Scholar
  • 12 Hakamori S. I. Glycosphingolipids in cellular interaction, differentiation and oncogenesis. Ann. Rev. Biochem 1981; 50: 733.
    CrossrefPubMedGoogle Scholar
  • 13 Kasai M., Iwamori N., Nagai Y.. et al. A glycolipid on the surface of mouse natural killer cells. Eur. J. Immunol 1980; 10: 175-80.
    CrossrefPubMedGoogle Scholar
  • 14 Keenan T. W, Morre D. J. Mammary carcinoma enzymatic block in disialoganglioside biosynthesis. Science 1973; 182: 935-7.
    CrossrefPubMedGoogle Scholar
  • 15 Lemieux R. U. The binding of carbohydrate structures with antibodies and lectins. In: Frontiers of Chemistry. 3-24 Pergamon Press; Oxford: 1982
    Google Scholar
  • 16 Longenecker B. M, Rahman A. F. R., Barrington-Leigh J.. et al. Monoclonal antibody against a cryptic carbohydrate antigen of murine and human lymphocytes. Int. J. Cancer 1984; 33: 123-9.
    CrossrefPubMedGoogle Scholar
  • 17 Magnani J. L, Brockhaus M., Smith F. D. et al. A monosialoganglioside is a monoclonal antibody defined antigen of colon carcinoma. Science 1981; 212: 55-6.
    CrossrefPubMedGoogle Scholar
  • 18 Nakahara K., Ohashi T., Oda T.. et al. Asialo GM1, as well as a cell-surface marker detected in acute lymphoblastic leukemia. New Engl. J. Med 1980; 302: 674-7.
    CrossrefPubMedGoogle Scholar
  • 19 Noujaim A. A, Shysh A., Zabel P.. et al. Thomsen-Friedenreich antigen: An important marker for the radioimmunodetection of cancer using macromolecular probes. In: Radioimmunoimaging and Radioimmunotherapy. 276-98 Elsevier Press; Amsterdam: 1983
    Google Scholar
  • 20 Rahman A FR., Longenecker M. B. A monoclonal antibody specific for the Thomsen-Friedenreich cryptic T antigen. J. Immunol 1982; 129: 2021-4.
    PubMedGoogle Scholar
  • 21 Ratcliffe R. M, Baker A. D, Lemieux U. R. Synthesis of the T (β-D-Gal- (1 → 3)-GalNAc) antigenic determinant in a form useful for the preparation of an effective artificial antigen and the corresponding immunoadsorbent. Carbohydrate Res 1981; 93: 35-41.
    CrossrefPubMedGoogle Scholar
  • 22 Shysh A., Boniface G. R, Eu S. M. et al. Kidney uptake of 125I-peanut lectin in mice. In: Current Applications in Radiopharmacology. Billinghurst M.. ed. 245-55 Pergamon Press; Oxford: 1986
    Google Scholar
  • 23 Shysh A., Eu S. M, Noujaim A. A. et al. Radioimmunodetection of murine mammary adenocarcinoma TA3/HA lung and liver metastases with radioiodinated PNA. Int. J. Cancer 1985; 35: 113.
    CrossrefPubMedGoogle Scholar
  • 24 Springer G.. T and Tn, general carcinoma autoantigens. Science 1984; 224: 1198-206.
    CrossrefPubMedGoogle Scholar
  • 25 Taggart R. T, Samloff I. F. Stable antibody-producing murine hybridomas. Science 1983; 219: 1228-30.
    CrossrefPubMedGoogle Scholar
  • 26 Turner C. J, Sykes T., Gaudreault R.. et al. Determination of metal ion impurities in radiogallium preparations and their effects on radiolabeling of chelated proteins. In: Current Applications in Radiopharmacology. Billinghurst M.. ed. 309-15 Pergamon Press; Oxford: 1986
    Google Scholar
  • 27 Yeh M. Y, Hellstrom I., Abe K.. et al. A cell surface antigen which is present in the ganglioside fraction and shared by human melanomas. Int. J. Cancer 1982; 29: 269-75.
    CrossrefPubMedGoogle Scholar
  • 28 Zabel P. L, Noujaim A. A, Shysh A., Bray J.. Radioiodinated peanut lectin: A potential radiopharmaceutical for immunodetection of carcinoma expressing the T-antigen. Eur. J. nucl. Med 1983; 08: 250-4.
    CrossrefPubMedGoogle Scholar